Carly's Law to be studied at UAB

One bill that did come out of this session became law earlier this week with the governor's signature is Carly's Law.

Carly's Law permits the University of Alabama at Birmingham to conduct a study of a marijuana derivative used to treat seizures. This is going to take some time.

UAB must still go through several levels of government regulation, including the Food and Drug Administration and the Drug Enforcement Administration.{}

Researchers expect it to take six months to cross those regulatory hurdles.

Dr. David Standaert is chair of UAB's department of neurology. He says UAB looks forward to studying the effects and usefulness of cannabidiols in treating seizures. As well as learning more about the{} effectiveness in patients.

Standaert knows there will be interest in this treatment.

He's encouraging people who meet the criteria, to take part in the testing and research of these oils.

The department is considering ways to determine who can participate in this program.

"Our approach is going to be to create a panel of physicians, pediatric neurologists, adult neurologists, some pharmacists, legal council and our intent is to involve some community participation by people who have epilepsy in that committee, that will decide whether this particular situation is appropriate or not," says Standaert.

Dr. Standaert says they will require medical records from patients who are wanting to inquire about the cannabidiol program.{}

They want to make sure each candidate is appropriate and does suffer from seizures or epilepsy.

Anyone who is interested in the cannabidiol program should contact UAB at (205) 975-8883.